SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-012259
Filing Date
2019-03-05
Accepted
2019-03-05 16:53:26
Documents
4
Period of Report
2019-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv515505_8k.htm 8-K 27773
2 EXHIBIT 99.1 tv515505_ex99-1.htm EX-99.1 14054
3 GRAPHIC image_001.jpg GRAPHIC 3556
4 GRAPHIC image_002.jpg GRAPHIC 3551
  Complete submission text file 0001144204-19-012259.txt   53439
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15070 | Film No.: 19659230
SIC: 2834 Pharmaceutical Preparations